(11) Patent Number | 034822 |
Date of Registration in the Register of Eurasian Patents | 2020.03.24 |
(21) Application Number | 201790637 |
(22) Filling Date | 2015.10.08 |
(51) IPC |
C07D 401/14 (2006.01)
C07D 405/14 (2006.01)
C07D 413/14 (2006.01)
A61K 31/4427 (2006.01)
C07D 409/14 (2006.01)
C07D 417/14 (2006.01)
A61P 35/00 (2006.01) |
(43)(13) Application Publication Date(s), Kind Code(s) | A1 2017.10.31 Issue No 10 title, specification
|
(45)(13) Patent Publication Date(s), Kind Code(s) | B1 2020.03.25 Issue No 03 title, specification B9 2020.10.23 Issue No 10 title, specification
|
(31) Number(s) assigned to Priority Application(s) | 1417829.7 1511387.1
|
(32) Date(s) of filing of Priority Application(s) | 2014.10.08 2015.06.29
|
(33) Priority Application Office | GB GB
|
(86) PCT Application Number | GB2015/052939 |
(87) PCT Publication Number | 2016/055786 2016.04.14 |
(71) Applicant(s) | РЭДКС ФАРМА ПИЭЛСИ (GB) |
(72) Inventor(s) | Бхамра Индер, Бингхэм Матильда, Тестар Ричард, Саржент Луис, Донахъю Крейг (GB) |
(73) Patent Owner(s) | РЭДКС ФАРМА ПИЭЛСИ (GB) |
(54) Title | ПРОИЗВОДНЫЕ N-ПИРИДИНИЛАЦЕТАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ СИГНАЛЬНОГО ПУТИ WNT |